Diabetic nephropathy (Q73376191)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167651%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Diabetic nephropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167651%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

M H Lapuz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167651%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167651%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167651%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167651%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167651%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

679-688

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167651%20AND%20SRC:MED&resulttype=core&format=json

Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. American Diabetes Association and the National Kidney Foundation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Treatment of hypertension in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease: Possible alternative drug therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Declining Incidence of Nephropathy in Insulin-Dependent Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Lilly Lecture 1993. Glycation and diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Early diabetic nephropathy. Emerging treatment options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Effect of adrenergic blocking agents on insulin response to glucose infusion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Prevention and treatment of the complications of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Hypolipidemic effects of long-term antihypertensive treatment with captopril. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

The effect of dietary protein restriction on the progression of diabetic nephropathy. A 12-month follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Captopril and insulin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Noninsulin-dependent diabetes mellitus. The prevention of complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Nutrition principles for the management of diabetes and related complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Forum One: Current recommendations about intensification of metabolic control in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Aggravation of diabetes mellitus during treatment with chlorothiazide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary Kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

The role of aldose reductase in the development of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Prevention of diabetic renal disease with special reference to microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Drug Treatment of Hypertension in Patients With Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Effect of chronic administration of propranolol on lipoprotein composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Diuretic treatment of hypertension in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970539-3

10.1016/S0025-7125(05)70539-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167651%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference